ImmuPharma signs collaboration with Imperial College London

LONDON, UK: ImmuPharma Plc, the specialist drug discovery and development company, has signed a 2-year collaboration agreement with Imperial College London. Under the collaboration, Imperial College will provide significant intellectual input and guidance on a number of innovative peptide assets being developed at the R&D subsidiary, ImmuPharma Biotech in Bordeaux. Dr Tim Franklin, Chief Operating…

Imperial College London upgrades to Vicon’s solutions

LONDON: Oxford Metrics plc the international software company servicing government, life sciences, entertainment and engineering markets announced that Vicon, a world leader in motion measurement, has signed a contract with Imperial College London, a global top ten university, to upgrade to both its flagship Vantage solution and flexible Vero solution. The Human Performance Group, part…